Jun 2026 (Q2 FY26) — Aug 11, 2026
Quantinuum Q2 FY26 — Strong Bookings and Strategic Partnerships Drive Upsized Revenue Outlook
Read the full callQuantinuum earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 8.0 | +279.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -6939.6 | −4516.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -65.4 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
YTD: $60.38 on 4 Jun 2026 → $34.93. High $83.17 (6 Jul 2026), low $33.03 (14 Oct 2026).
Overview
Call summaries
Quantinuum Q2 FY26 — Strong Bookings and Strategic Partnerships Drive Upsized Revenue Outlook
Read the full callEvery analysed call
Financials
| Line item | Jun 2025 | Jun 2026 |
|---|---|---|
| Sales | 2 | 8 |
| Expenses | 53 | 563 |
| Operating profit | -51 | -555 |
| Operating margin | −2423.5% | −6939.6% |
| Profit before tax | -57 | -596 |
| Tax rate | 0.0% | −0.1% |
| Net profit | — | -65 |
| EPS ($ per share) | — | -1.93 |
25 filings between Jun 3, 2026 and Jul 17, 2026.
Purchases
$24.66M
11 purchases by 11 insiders
Sales
None
No insider sold shares.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Barron Hal | $15.00M | — | Jun 5, 2026 |
| JIMENEZ JOSEPH | $4.00M | — | Jun 5, 2026 |
| BHATIA MANISH H | $1.20M | — | Jun 5, 2026 |
| Dehoff Kevin Scott | $900.0K | — | Jun 5, 2026 |
| DENMAN KENNETH D | $840.0K | — | Jun 5, 2026 |
| Stepniak Michal | $800.0K | — | Jun 5, 2026 |
| Kapur Vimal | $780.0K | — | Jun 5, 2026 |
| Branderiz Eric | $500.0K | — | Jun 5, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Schulman Robin CLO & Corporate Secretary | Award | 125,000 | $0 |
| Jun 5, 2026 | Branderiz Eric Director | Purchase | 8,334 | $500.0K |
| Jun 5, 2026 | Narang Prineha Director | Purchase | 200 | $12.0K |
| Jun 5, 2026 | BHATIA MANISH H Director | Purchase | 20,000 | $1.20M |
| Jun 5, 2026 | DENMAN KENNETH D Director | Purchase | 14,000 | $840.0K |
| Jun 5, 2026 | Daugherty Paul R. Director | Purchase | 4,000 | $240.0K |
| Jun 5, 2026 | Dehoff Kevin Scott Chief Strategy Officer | Purchase | 15,000 | $900.0K |
| Jun 5, 2026 | Stepniak Michal Director | Purchase | 13,333 | $800.0K |
| Jun 5, 2026 | Kapur Vimal Director | Purchase | 13,000 | $780.0K |
| Jun 5, 2026 | Barron Hal Director | Purchase | 250,000 | $15.00M |
| Jun 5, 2026 | SHARAN NITESH Chief Financial Officer | Purchase | 6,500 | $390.0K |
| Jun 5, 2026 | JIMENEZ JOSEPH Director | Purchase | 66,665 | $4.00M |
| Jun 4, 2026 | DENMAN KENNETH D Director | Award | 5,833 | $0 |
| Jun 4, 2026 | Branderiz Eric Director | Award | 5,833 | $0 |
| Jun 4, 2026 | Daugherty Paul R. Director | Award | 5,833 | $0 |
| Jun 4, 2026 | JIMENEZ JOSEPH Director | Award | 5,833 | $0 |
| Jun 4, 2026 | SHARAN NITESH Chief Financial Officer | Award | 44,548 | $0 |
| Jun 4, 2026 | Narang Prineha Director | Award | 5,833 | $0 |
| Jun 4, 2026 | Hazra Rajeeb President & CEO | Award | 78,333 | $0 |
| Jun 4, 2026 | BHATIA MANISH H Director | Award | 5,833 | $0 |
| Jun 4, 2026 | Barron Hal Director | Award | 5,833 | $0 |
| Jun 3, 2026 | SHARAN NITESH Chief Financial Officer | Award | 289,798 | — |
| Jun 3, 2026 | Hazra Rajeeb President & CEO | Award | 1,042,561 | — |
| Jun 3, 2026 | Hazra Rajeeb President & CEO | Tax withheld | 336,389 | $20.18M |
| Jun 3, 2026 | Dehoff Kevin Scott Chief Strategy Officer | Award | 111,460 | — |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Quantinuum Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading